I hear lots of conflicting analysis from investors that I respect regarding the rest of the space sector. Can you do an analysis on $ASTS
Some believe the support that it’s on will hold others believe it has been technically damaged and that this cycle is over and will take time to regain its upward trend again
@cfcmatchchat25@CFC_OBED Without him Chelsea never even makes the UCL from the season before and in the UCL he was MoM against Real Madrid in semi finals and MoM against Porto. Be thankful he was on your squad
@Nyaokeis@GeronimoMorgans He’s been one of the top 3 players on Italy until his most recent injury. Now he’s back to form. He’s been Milan’s top player
He’s been following them forever. I’ve seen clips of him at many games this season. He’s also a pretty knowledgeable dude when it comes to sports, I saw him on a Saturday college espn game day show and he was dropping lots of football knowledge bombs that your average casual wouldn’t know.
He’s a sports dude
I love the company and I believe it could end up being the largest company on the planet in the next 5-10 years. With that said, the price will most likely go through the roof on the first day or two and then I plan on shorting it and I think it will take a couple years before the price returns to its opening day price.
As someone with a substantial position in $NVO, a 3% green day doesn't erase a 40% drawdown over the last 6 months. I’m down about 10% on my position. Eli Lilly ($LLY) has definitely been the winner here—and will likely stay ahead, which is why my LLY position is even bigger—but NVO is getting completely disrespected at these low valuations.
@richardgalaxia There is a such thing as capital and he shouldn’t deploy that capital unless he thinks there is a decent chance of an ROI. Collins has to do more to earn that endorsement, meaning he needs to show some glimmer of hope whether it’s fundraising or polling or something.